CounterPath Overview
Latest ROE for CounterPath: -45.62% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-45.62%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CounterPath (CPAH) currently reports a ROE of -45.62%. That is below the Technology sector average of 47.96%. Use the charts on this page to explore CounterPath's ROE history and peer comparisons.
CounterPath's ROE of -45.62% is lower than the Technology sector average of 47.96%. That is roughly 195.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CounterPath's current -45.62% should be judged against Technology norms (sector average: 47.96%) and against CPAH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -45.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.96%. From there, open related valuation or income-statement pages for CounterPath, and consider following CPAH for alerts when major investors trade the stock.
CounterPath is classified in the Technology sector. On ROE, it currently shows -45.62% versus a sector average near 47.96%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing CPAH with unrelated industries.
